Peter A. Everts, Ph.D., FRSM
Chief Scientific Officer, EmCyte Corp., Fort Myers FL
Program Director, Gulf Coast Biologics, Fort Myers FL
Fellow Royal Society of Medicine, London, UK
Professor, Max Planck University OrthoRegen, Indaiatuba, Sao Paulo Brazil
International Professor, Frontiers Health Program, Faculty of Medicine, Max Planck University Center, Brazil
Innovative researcher and clinical practitioner in the field of regenerative-orthobiological medicine applications, with extensive teaching and educational program development experience. Analytical strategist skilled in successfully navigating evidence based clinical protocols and application technologies through the concept, development, and implementation phases of new healthcare medicine initiatives. Collaborative communicator continually focused on building relationships and promoting cellular therapy programs across educational, and business lines, and global healthcare organizations to drive positive transformation of regenerative medicine concepts, cohesive marketing approaches, and enhanced profitability. Comfortable and experienced teacher for physicians and health care providers in autologous biologics. Professor Everts is an Internationally recognized educator, scientist, and contributor in a variety of regenerative medicine applications, featuring blood-derived products He has published over 70 peer reviewed articles, including the first textbook on Platelet-Rich Plasma. He is the Chief Scientific Officer of EmCyte Corp. and Program director of Gulf Coast Biologics Research & Educational Center. Recently appointed International Professor at the Frontiers Health Program of the Faculty of Medicine of the Max Planck University Center (Indaiatuba – Sao Paulo Brasil). His responsibilities include teaching and management of clinical projects in non-interventional regenerative and orthobiological therapies.